UNSPSC 51334404: Citatepine

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51334404

Definition

This classification denotes a dopamine antagonist with the molecular formula C20H18N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 92S48G7U0W, chemically known as 2,3,4,5-tetrahydro-3-methyl-1h-dibenzo(2,3:6,7)thiepino(4,5-d)azepine-7-carbonitrile. but generally known as citatepine, which bears US NIH Compound Identifier 193991. European Medicines Agency schedules Citatepine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07486MIG.

Read the full definition

The term CITATEPINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). CITATEPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule citatepine under HS 29349990 and SITC 51579. As of Q4 2014, CITATEPINE remains the US FDA Preferred Term for this commodity. Citatepine bears US NLM identifiers UMLS ID C2699334 and NCI Concept Code C77570. SMILES: S1C2C(C3=C(CCN(CC3)C)C3C1CCCC3)CC(CC2)C#N.

About UNSPSC 51334404

UNSPSC 51334404 Citatepine is a Commodity code that in recent state and local procurement activity covers pharmaceutical products and medical supply systems, specifically naloxone and drug deactivation equipment procured for community health and public safety initiatives. State and local health departments and county government agencies are the primary issuing bodies soliciting under this code, typically through competitive bidding processes to support emergency response and substance-abuse mitigation programs. The work involves procurement of finished pharmaceutical products and associated medical devices in quantities ranging from hundreds to thousands of units annually, with vendors required to meet standard compliance requirements including drug-free workplace certification, E-Verify eligibility verification, and appropriate insurance coverage.

Seminole County, Florida represents the most recent documented activity under the code, issuing IFB 60459723LAS in June 2026 (posted Jul 30, 2026, response due Jul 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The procurement specifies a two-year initial term with an optional one-year renewal, fixed-fee pricing, and potential FEMA funding with associated federal compliance requirements. Vendors must include all shipping and delivery costs in their proposals and submit bids electronically through the county's e-Procurement Portal. Beyond this recent Seminole County solicitation, the source provides no additional state or local opportunities under the code and does not support characterization of broader geographic spread or repeat-buyer patterns.

Quick answers

What is UNSPSC 51334404?

UNSPSC 51334404 is Citatepine, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51334404?

UNSPSC 51334404 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51334404

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code